Sustained Virologic Response (SVR) in Hepatitis C (HCV) Patients Does Not Demonstrate Differences in Physical Performance, Fatigue, Sleep, and Health-related Quality of Life (HRQL): 410Price, JillianEscheik, CareyAzim, YusufHunt, SharonFang, Yun...
This outcome, called a sustained virological response (SVR), means that a person achieves and maintains undetectable HCV levels for at least six months after completing a course of pegylated interferon and ribavirin treatment, which is the standard of care for hepatitis C. People who achieve an ...
Despite the remarkable improvements in pharmacologic treatment efficacy for hepatitis C (HCV) reported in published clinical trials, published research suggests that, in "real-world" patient care, these medical outcomes may be difficult to achieve. This review was undertaken to summarize recent experienc...
Genome-wide association of IL28B with fibrosis progression in patients with chronic hepatitis C. Lancet response to pegylated interferon-alpha and ribavirin therapy 1997; 349: 825–832. for chronic hepatitis C. Nat Genet 2009; 10: 1105–1109. 7 Blonski W, Reddy KR. Hepatitis C virus infection...
Recently published data showed a link between sustained virologic response and a reduced risk for hepatocellular carcinoma among patients treated with direct-acting antivirals for hepatitis C. “Data on HCC risk following DAA induced SVR are still sparse and conflicting,”Fasiha Kanw...
Patients' Willingness to Accept the Risks and Benefits of New Treatments for Chronic Hepatitis C Virus Infection sustained virologic response [SVR]); weeks on an additional, third medicine (i.e. a DAA); risk of a severe rash; risk of severe anemia; and ... T Kauf,A Mohamed,A Hauber,....
Durability of SVR in chronic hepatitis C patients treated with peginterferon-alpha2a/ribavirin in combination with a direct-acting anti-viral. Aliment Pharmacol Ther. 2013;38(2):118–23.Mishra A, Younossi Z. Commentary: durability of SVR in chronic hepatitis C patients treated with peginterferon-...
M1791 Role of Rvr and Viral Load On SVR in Treatment of GT3 Hepatitis C Patients with Peginterferon Alfa-2a (PEG) and Ribavirin (RBV) in Real Life Summary. Guidelines for the treatment of patients infected with hepatitis C virus of genotypes 2 and 3 (HCV-2 and HCV-3, respectively) reco...
somepatients, these data represent a significant advance in the race to develop a new, all-oral treatment for Hepatitis C," said Professor Markus Peck-Radosavljevic, Secretary-General of the European Association for the Study of the Liver and Associate Professor of Medicine, University of Vienna,...
Meta-analysis: sustained virologic response (SVR) in patients with infection with hepatitis C virus genotype 5 (HCV-5) versus genotype 1 (HCV-1) and HCV genotype 2/3(HCV -2/3) treated with interferon or pegylated interferon and ribavirin (PEG IFN+RBV). Gastroenterology 2014, in press....